Brief: Teladoc Health Q2 EPS USD -0.21
29/07/2026 21:06
BRIEF-Teladoc Health Q2 EPS USD -0.21 Jul 29 (Reuters) - Teladoc Health Q2 revenue USD 606.927 million vs. IBES estimate USD 615.4 million.
- Q2 basic EPS USD -0.21
- Q2 adjusted EBITDA USD 65.713 million vs. IBES estimate USD 62 million
- Q2 net income USD -38.908 million
- outlook Q3 EPS USD -0.3 to -0.2
- outlook FY revenue USD 2,362-2,447 million vs. IBES estimate USD 2,508 million
- outlook FY adjusted EBITDA USD 271-303 million vs. IBES estimate USD 279.8 million
- outlook Q3 adjusted EBITDA USD 62-74 million vs. IBES estimate USD 74.4 million
- outlook FY EPS USD -1 to -0.75
- outlook Q3 revenue USD 569-609 million vs. IBES estimate USD 629.3 million
Recent news on Teladoc Health
See all newsTeladoc appoints insurance executive Michael Grasher as CFO
U.S. STOCKS ON THE MOVE-Mastercard, Yum, Equinix
U.S. STOCKS ON THE MOVE-Mastercard, Starbucks, Meta
Teladoc tumbles on revenue forecast cut as BetterHelp demand shifts hurt (updated)
U.S. STOCKS ON THE MOVE-Avery Dennison, Huntington Ingalls, XPO